It is more important than ever that the healthcare community worldwide unite and work together in an inclusive environment. The Endocrine Society has always welcomed our international members and strived to offer relevant benefits across the globe. I am happy to report on several new initiatives to increase our international cooperation with the goal of improving patient care.
Collaboration with the European Society of Endocrinology on Clinical Practice Guidelines
The Endocrine Society and the European Society of Endocrinology (ESE) have reached a historic agreement to jointly develop Clinical Practice Guidelines providing evidence-based recommendations for clinical care and practice. Developing globally relevant guidelines will support the delivery of up-to-date care to patients worldwide. The joint Clinical Practice Guideline program also will recognize global differences in access to diagnostic tools and therapies. This collaboration will kick off with the development of two inaugural guidelines: Diabetes in Pregnancy, led by the Endocrine Society, and Management of Corticosteroid Therapy, led by the European Society of Endocrinology.
We look forward to growing our global outreach, both virtually and, eventually, in person, to continue pursuing our mission to unite, lead, and grow the global endocrine community.
We hope that this collaboration will be just the first of many opportunities to work collaboratively with the European Society of Endocrinology. This partnership establishes our organizations as international leaders in this effort and will serve as a model for international cooperation throughout the endocrine community. I see this as opportunity for our organizations to learn and grow with the goal of providing the best care to patients worldwide.
Partnering with International Societies
Since ENDO Online 2020, we have partnered with several endocrine-related sister societies from around the world by participating in their own virtual meetings. We have collaborated on educational sessions and/or invited member speakers to virtually partake in the 22nd European Congress of Endocrinology e-ECE 2020 (September 5-9, 2020), EndoBridge in Turkey (October 22-24, 2020), The 17th Asia-Oceania Congress of Endocrinology and the 8th Seoul International Congress of Endocrinology and Metabolism (October 28-31, 2020), ENDORECIFE in Brazil (November 11-14, 2020), the 60th International Congress of the Mexican Society for Nutrition and Endocrinology (November 17-21, 2020), and the 34th Brazilian Congress of Endocrinology and Metabolism (November 28-December 5, 2020). We value these opportunities to collaborate with international societies and hope that such partnerships will help us achieve our shared mission to accelerate scientific breakthroughs and improve patient care worldwide.
We value these opportunities to collaborate with international societies and hope that such partnerships will help us achieve our shared mission to accelerate scientific breakthroughs and improve patient care worldwide.
The participation of international members (and non-members) to our two most recent virtual events is evidence of how the global endocrine community has no barriers. At ENDO Online 2020, over 70% of the 27,000 registrants were from outside the U.S., spanning 140 countries. In mid-September, we held a virtual Clinical Endocrinology Update where 40% of the 1,090 participants were international, representing 49 countries.
We look forward to growing our global outreach, both virtually and, eventually, in person, to continue pursuing our mission to unite, lead, and grow the global endocrine community.
Gary D. Hammer, MD, PhD
President, Endocrine Society
Loading ...